Hong Kong Journal of Nephrology
Volume 8, Issue 1 , Pages 17-23 , April 2006

Comparison of Atorvastatin and Simvastatin in the Long-term Treatment of Hyperlipidemia After Kidney Transplantation

References 

  1. Andany MA , Kasiske BL . Dyslipidemia and its management after renal transplantation . J Nephrol . 2001;14(Suppl 4):S81–S88
  2. Hricik DE , Mayes JT , Schulak JA . Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia . Am J Kidney Dis . 1991;18:353–358
  3. Kobashigawa JA , Kasiske BL . Hyperlipidemia in solid organ transplantation . Transplantation . 1997;63:331–338
  4. Pannus HS , Singh D , Sandhu JS . Lipid profile before and after renal transplantation - a longitudinal study . Ren Fail . 2003;25:411–417
  5. Quaschning T , Mainka T , Nauck M , Rump LC , Wanner C , Kramer-Guth A . Immunosuppression enhances atherogenicity of lipid profile after transplantation . Kidney Int Suppl . 1999;71:S235–S237
  6. Hines L . Can low-fat/cholesterol nutrition counselling improve food intake habits and hyperlipidemia of renal transplant patients? . J Ren Nutr . 2000;10:30–35
  7. Tonstad S , Holdaas H , Gorbitz C , Ose L . Is dietary intervention effective in post-transplant hyperlipidemia? . Nephrol Dial Transplant . 1995;10:82–85
  8. Arnadottir M , Berg AL . Treatment of hyperlipidemia in renal transplant recipients . Transplantation . 1997;63:339–345
  9. Massey ZA , Kasiske BL . Post-transplant hyperlipidemia: mechanisms and management . J Am Soc Nephrol . 1996;7:971–977
  10. Jones P , Kafonek S , Laurora I , Hunninghake D . Comparative dose efficacy of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The Curves Study) . Am J Cardiol . 1998;81:582–587
  11. Renders L , Mayer-Kadner I , Koch C , Scharffe S , Burkhardt K , Veelken R , et al.   Efficacy and drug interactions of the new HMG CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients . Nephrol Dial Transplant . 2001;16:141–146
  12. Martinez-Castelao A, Grinyo JM, Gil-Vernet S, Seron D, Castineiras MJ, Ramos R, et al. Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression . Transplant Proc . 2002;34:398–400
  13. Lepre F , Rigby R , Hawley C , Saltissi D , Brown A , Walsh Z . A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidemia in renal allograft recipients . Clin Transplant . 1999;13:520–525
  14. Rehman MA , al-Sulaiman MH , Mousa DH , al-Hawas FA , Abdalla AH , Rassoul Z , et al.   Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine . Transplantation . 1995;60:397–399
  15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults  . Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) . JAMA . 2001;285:2486–2497
  16. Vathsala A , Weinberg RB , Schoenberg L , Grevel J , Goldstein RA , Van Buren CT , et al.   Lipid abnormalities in cyclosporineprednisone-treated renal transplant recipients . Transplantation . 1989;48:37–43
  17. Capone D , Stanziale P , Gentile A , Imperatore P , Pellegrino T , Basile V . Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients . Am J Nephrol . 1999;19:411–415
  18. Chan TM , Cheng IKP , Tam SCF . Hyperlipidemia after renal transplantation: treatment with gemfibrozil . Nephron . 1994;67:317–321
  19. Alvarez ML , Errasti P , Gomez G , Lavilla FJ , Garcia N , Ballester B , et al.   Effect of atorvastatin on the treatment of hyper-cholesterolemia after renal transplantation . Transplant Proc . 1999;31:2328–2329
  20. Davidson M , Mckenny J , Stein E , Schrott H , Bakker-Arkema R , Fayyad R , et al.   Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia . Am J Cardiol . 1997;79:1475–1481
  21. Danesh FR , Anel RL , Zeng L , Lomasney J , Sahai A , Kanwar YS . Immunomodulatory effects of HMG-CoA reductase inhibitors . Arch Immunol Ther Exp . 2003;51:139–148
  22. Bakker-Arkema R , Davidson M , Goldstein R , Davignon J , Isaacsohn JL , Weiss SR , et al.   Efficacy and safety of a new HMG-Co A reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia . JAMA . 1996;275:128–133
  23. Asberg A , Hartmann A , Fjeldsa E , Holdaas H . Atorvastatin improves endothelial function in renal-transplant recipients . Nephrol Dial Transplant . 2001;16:1920–1924
  24. Mora C , Rodriguez ML , Navarro JF . Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin . Transplantation . 2001;72:551
  25. Holdaas H , Fellstrom B , Jardine AG , Holme I , Nyberg G , Fauchald P , et al.   Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial . Lancet . 2003;361:2024–2031
  26. Romero R , Calvino J , Rodriguez J , Sanchez-Guisande D . Short-term effect of atorvastatin in hypercholesterolaemic renaltransplant patients unresponsive to other statins . Nephrol Dial Transplant . 2000;15:1446–1449
  27. Demetriou D , Shabpar A , Bohmig G , Schmaldienst S , Horl WH , Watschinger B . Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation . Wien Klin Wochenschr . 2000;112:358–361
  28. Austin MA , Hokanson JE , Edwards KL . Hypertriglyceridemia as a cardiovascular risk factor . Am J Cardiol . 1998;81:7B–12B
  29. Asberg A , Hartmann A , Fjeldsa E , Bergan S , Holdaas H . Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients . Am J Transplant . 2001;1:382–386
  30. Marz W , Koenig W . HMG-CoA reductase inhibition: antiinflammatory effects beyond lipid lowering? . J Cardiovasc Risk . 2003;10:169–179
  31. Blanco-Colio LM , Tunon J , Martin-Ventura JL , Egido J . Anti-inflammatory and immunomodulatory effects of statins . Kidney Int . 2003;63:12–23
  32. Crisby M . Modulation of the inflammatory process by statins . Drugs Today . 2003;39:137–143
  33. Kendrick E . Cardiovascular disease and the renal transplant recipient . Am J Kidney Dis . 2001;38(6 Suppl 6):S36–S43
  34. Guijarro C , Massy ZA , Kasiske BL . Clinical correlation between renal allograft failure and hyperlipidemia . Kidney Int Suppl . 1995;52:S56–S59
  35. Dimeny E , Wahlberg J , Lithell H , Fellstrom B . Hyperlipidemia in renal transplantation -risk factor for long-term graft outcome . Eur J Clin Invest . 1995;25:574–583

PII: S1561-5413(09)60225-8

doi: 10.1016/S1561-5413(09)60225-8

Hong Kong Journal of Nephrology
Volume 8, Issue 1 , Pages 17-23 , April 2006

Article Tools